Zwerling, Schachter & Zwerling

Zwerling, Schachter & Zwerling, LLP is a boutique law firm founded in 1985 that specializes in complex class action litigation, particularly in the areas of securities fraud, antitrust, and consumer rights. Headquartered in New York City with additional offices in Seattle and Garden City, the firm has a long history of representing institutional and individual investors in high-profile cases against major corporations. While not a life sciences company itself, the firm is frequently involved in litigation within the healthcare and pharmaceutical industries, such as antitrust cases involving generic drug entry and securities fraud actions. The firm is recognized for its expertise in federal securities class actions and has secured numerous multi-million dollar settlements for its clients. It has played leading roles in major litigations such as the Stanford Financial Group Ponzi scheme and various pharmaceutical antitrust actions.